Example: Heart Attack

Clinical Trials on Lymphangiomyoma

Total 39 results

    • NCT00552955
      Completed
      Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
      Conditions: Lymphangioleiomyomas; Tuberous Sclerosis; Lymphangioleiomyomatosis
    • NCT00005906
      Completed
      Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis; Lymphangiomyomas; Pleural Effusions; Ascites
    • NCT04388371
      Enrolling by invitation
      Glutamine PET Imaging in LAM
      Conditions: Lymphangioleiomyomatosis (LAM)
    • NCT04184193
      Completed
      Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)
      Conditions: Lymphangioleiomyomatosis; LAM; Pulmonary Rehabilitation
    • NCT03253913
      Unknown status
      Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial
      Conditions: Lymphangioleiomyomatosis
    • NCT03193892
      Unknown status
      A National Registry on Chinese Patients With Lymphangioleiomyomatosis
      Conditions: Pulmonary Function
    • NCT03150914
      Recruiting
      Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
      Conditions: LAM; Lymphangioleiomyomatosis
    • NCT03131999
      Completed
      LAM Pilot Study With Imatinib Mesylate
      Conditions: Lymphangioleiomyomatosis
    • NCT03062943
      Recruiting
      A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
      Conditions: Lymphangioleiomyomatosis
    • NCT02737202
      Terminated
      Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
      Conditions: Pulmonary Lymphangioleiomyomatosis
    • NCT02484664
      Completed
      COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
      Conditions: Lymphangioleiomyomatosis (LAM)
    • NCT02432560
      Active, not recruiting
      Safety and Durability of Sirolimus for Treatment of LAM
      Conditions: Lymphangioleiomyomatosis
    • NCT02116712
      Completed
      The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
      Conditions: Pulmonary Lymphangioleiomyomatosis
    • NCT02009241
      Completed
      Pulmonary Rehabilitation in Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis
    • NCT01799538
      Recruiting
      Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis
    • NCT03304678
      Recruiting
      Discovery of Sirolimus Sensitive Biomarkers in Blood
      Conditions: Lymphangioleiomyomatosis
    • NCT01687179
      Completed
      Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis
    • NCT01484236
      Recruiting
      National Lymphangioleiomyomatosis Registry, France
      Conditions: Lymphangioleiomyomatosis
    • NCT01353209
      Completed
      Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis
    • NCT01059318
      Completed
      A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
      Conditions: Lymphangioleiomyomatosis
    • NCT00414648
      Unknown status
      Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
      Conditions: Lymphangioleiomyomatosis
    • NCT00001869
      Completed
      Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
      Conditions: Leiomyomatosis
    • NCT04577937
      Recruiting
      Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis
      Conditions: Lymphangioleiomyomatosis; Sleep Disorder; Sleep Apnea Syndromes; Hypopnea Syndrome
    • NCT02859194
      Completed
      The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
      Conditions: Interstitial Pulmonary Fibrosis ARDS; COPD (Chronic Obstructive Pulmonary Disease); Bronchiectasis; Lymphangioleiomyomatosis; Primary Pulmonary Hypertension; ARDS (Acute Respiratory Distress Syndrome)
    • NCT00005486
      Completed
      Lymphangioleiomyomatosis (LAM) Registry
      Conditions: Lung Diseases; Lymphangiomyomatosis
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations